- Home
- ASRT vs NVCT Comparison
ASRT vs NVCT Comparison
Compare ASRT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- NVCT
- Stock Information
- Founded
- ASRT 1995
- NVCT 2020
- Country
- ASRT United States
- NVCT United States
- Employees
- ASRT N/A
- NVCT N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- ASRT Health Care
- NVCT Health Care
- Exchange
- ASRT Nasdaq
- NVCT Nasdaq
- Market Cap
- ASRT 85.1M
- NVCT 119.4M
- IPO Year
- ASRT 1997
- NVCT 2022
- Fundamental
- Price
- ASRT $0.86
- NVCT $5.22
- Analyst Decision
- ASRT Strong Buy
- NVCT Strong Buy
- Analyst Count
- ASRT 4
- NVCT 1
- Target Price
- ASRT $3.19
- NVCT $21.00
- AVG Volume (30 Days)
- ASRT 917.9K
- NVCT 94.1K
- Earning Date
- ASRT 11-11-2024
- NVCT 11-05-2024
- Dividend Yield
- ASRT N/A
- NVCT N/A
- EPS Growth
- ASRT N/A
- NVCT N/A
- EPS
- ASRT N/A
- NVCT N/A
- Revenue
- ASRT $125,763,000.00
- NVCT N/A
- Revenue This Year
- ASRT N/A
- NVCT N/A
- Revenue Next Year
- ASRT $1.84
- NVCT N/A
- P/E Ratio
- ASRT N/A
- NVCT N/A
- Revenue Growth
- ASRT N/A
- NVCT N/A
- 52 Week Low
- ASRT $0.73
- NVCT $4.44
- 52 Week High
- ASRT $1.80
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- ASRT 41.45
- NVCT 48.49
- Support Level
- ASRT $0.84
- NVCT $4.48
- Resistance Level
- ASRT $0.92
- NVCT $5.44
- Average True Range (ATR)
- ASRT 0.06
- NVCT 0.38
- MACD
- ASRT -0.00
- NVCT 0.14
- Stochastic Oscillator
- ASRT 22.30
- NVCT 69.00
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.